
Sign up to save your podcasts
Or


This University of Calgary researcher has signed a deal to develop nanomedicines for the treatment of Type 1 diabetes. Angela is joined by Pere Santamaria, Professor, Department of Microbiology, Immunology & Infectious Diseases at the University of Calgary.
By CHQR / CuriouscastThis University of Calgary researcher has signed a deal to develop nanomedicines for the treatment of Type 1 diabetes. Angela is joined by Pere Santamaria, Professor, Department of Microbiology, Immunology & Infectious Diseases at the University of Calgary.